Efficiency of Combined Therapy with Impaza and Type 5 Phosphodiesterase Inhibitors in Prophylactics of Posttraumatic Erectile Dysfunction

被引：0
|
作者：
Kh. S. Ibishev
机构：
[1] Rostov State Medical University,
来源：
Bulletin of Experimental Biology and Medicine | 2009年 / 148卷
关键词：
erectile dysfunction; trauma of the urethra; urethral stricture; impaza;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The use of combined pharmacotherapy with impaza and type 5 phosphodiesterase inhibitors helps to prevent and/or considerably reduce the risk of posttraumatic erectile dysfunction in men with traumas and strictures of the urethra. This therapy is indicated at early terms after trauma of the urethra for prophylactics of erectile dysfunction.
引用
收藏
页码：322 / 324
页数：2
相关论文
共 50 条
  • [21] Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors
    H Al-Ameri
    R A Kloner
    International Journal of Impotence Research, 2009, 21 : 149 - 157
  • [22] Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors
    Al-Ameri, H.
    Kloner, R. A.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2009, 21 (03) : 149 - 157
  • [23] Evolution of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction in Taiwan
    Jiann, Bang-Ping
    UROLOGICAL SCIENCE, 2016, 27 (02) : 66 - 70
  • [24] Drug Insight:: oral phosphodiesterase type 5 inhibitors for erectile dysfunction
    Briganti, A
    Salonia, A
    Gallina, A
    Saccà, A
    Montorsi, P
    Rigatti, P
    Montorsi, F
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (05): : 239 - 247
  • [25] Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction
    Alberto Briganti
    Andrea Salonia
    Andrea Gallina
    Antonino Saccà
    Piero Montorsi
    Patrizio Rigatti
    Francesco Montorsi
    Nature Clinical Practice Urology, 2005, 2 : 239 - 247
  • [26] An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors
    Bruzziches, Roberto
    Francomano, Davide
    Gareri, Pietro
    Lenzi, Andrea
    Aversa, Antonio
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (10) : 1333 - 1344
  • [27] Evaluation of the Efficiency and Safety of Combined Treatment with Impaza and Nitrates in CHD Patients with Erectile Dysfunction
    Zhavbert, E. S.
    Kachanova, M. V.
    Tarasov, S. A.
    Dugina, Yu. L.
    Sergeeva, S. A.
    Dovgalevskii, P. Ya.
    Epshtein, O. I.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 148 (02) : 325 - 327
  • [28] Evaluation of the Efficiency and Safety of Combined Treatment with Impaza and Nitrates in CHD Patients with Erectile Dysfunction
    E. S. Zhavbert
    M. V. Kachanova
    S. A. Tarasov
    Yu. L. Dugina
    S. A. Sergeeva
    P. Ya. Dovgalevskii
    O. I. Epshtein
    Bulletin of Experimental Biology and Medicine, 2009, 148
  • [29] Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus
    M A Vickers
    R Satyanarayana
    International Journal of Impotence Research, 2002, 14 : 466 - 471
  • [30] Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma
    Loeb, Stacy
    Folkvaljon, Yasin
    Lambe, Mats
    Robinson, David
    Garmo, Hans
    Ingvar, Christian
    Stattin, Par
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (24): : 2449 - 2455
12345